Erste Asset Management Gmb H Legend Biotech Corp Transaction History

Erste Asset Management Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Nov 26, 2024	SELL	$55.06 - $69.99 $1.91 Million - $2.43 Million	-34,700 Closed	0 $0
Q3 2023 Nov 26, 2024	BUY	$63.16 - $76.5 $1.58 Million - $1.91 Million	25,000 Added 257.73%	34,700 $2.34 Billion
Q3 2022 Nov 26, 2024	BUY	$38.15 - $57.1 $370,055 - $553,870	9,700 New	9,700 $389 Million
Q2 2022 Nov 26, 2024	BUY	$33.54 - $55.0 $325,338 - $533,500	9,700 New	9,700 $528 Million
Q1 2022 Nov 22, 2024	BUY	$31.02 - $48.18 $300,894 - $467,346	9,700 New	9,700 $358 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.63B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.